- Home
- LNTH vs IDA Comparison
LNTH vs IDA Comparison
Compare LNTH & IDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNTH | IDA |
|---|---|---|
| Founded | 1956 | 1915 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 7.0B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | LNTH | IDA |
|---|---|---|
| Price | $66.12 | $125.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $77.33 | ★ $133.00 |
| AVG Volume (30 Days) | ★ 1.0M | 385.8K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 2.79% |
| EPS Growth | N/A | ★ 7.17 |
| EPS | 2.39 | ★ 5.84 |
| Revenue | $1,525,933,000.00 | ★ $1,805,885,000.00 |
| Revenue This Year | $0.01 | $6.64 |
| Revenue Next Year | $1.24 | $7.70 |
| P/E Ratio | $27.84 | ★ $21.56 |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $47.25 | $104.74 |
| 52 Week High | $111.29 | $138.03 |
Technical Indicators
Market Signals| Indicator | LNTH | IDA |
|---|---|---|
| Relative Strength Index (RSI) | 72.55 | 40.80 |
| Support Level | $60.15 | $124.12 |
| Resistance Level | $64.40 | $127.42 |
| Average True Range (ATR) | 2.09 | 2.14 |
| MACD | 0.66 | -0.20 |
| Stochastic Oscillator | 94.44 | 23.05 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About IDA IDACORP Inc.
Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.